MedWatch·Industry news·Business & finance·3d agoWSA CEO expects to gain market share despite US headwindWSA's US market challenges and below-peer guidance signal potential competitive shifts in hearing aid distribution that could affect clinic partnerships and product availability.
Audiology Worldnews·Other·Hearing aids·4d agoDemant’s Man for All SeasonsLeadership perspectives from a major manufacturer's president can signal strategic shifts in product development, distribution, and market priorities that may affect audiologists and clinic owners over the coming years.+Save
MedWatch·Industry news·Business & finance·9d agoNew AI platform and Asia push to keep Sonova ahead of Demant: “We will continue to take share”Sonova's declared AI platform investment and Asia expansion signal a likely acceleration in AI-driven hearing aid features and increased global market competition, which could shape product availability and pricing for clinics worldwide.+Save
MedWatch·Industry news·Business & finance·12d agoDemant goes on offensive with US veterans: “We aim to steadily expand our position”Competition between major manufacturers for the VA contract shapes which hearing aids are most accessible to the large and high-need veteran population, potentially influencing device availability and pricing across the sector.+Save
Hearing Tracker·Industry news·Business & finance·2w agoUS Hearing Aid Market Rebounds in Q3 2026, Demant EstimatesA confirmed US market rebound after a downturn signals improved consumer demand, which may affect clinic revenue forecasts and inventory planning for hearing aid dispensers.+Save
Hearing Health Matters·Industry news·Business & finance·2w agoDemant Reports Strong Q3 Growth as Oticon Reveal Drives Hearing Aid SalesDemant's strong Q3 growth driven by a single new product launch reflects how rapidly the hearing aid market responds to new technology releases, with implications for competitor positioning and dispenser inventory decisions.+Save
MedWatch·Industry news·Business & finance·2w agoDemant CEO in continued focus on cybersecurity after new WSA attack: “I wish them all the best”Cyberattacks on major hearing aid manufacturers can disrupt supply chains, patient data systems, and clinical operations, making cybersecurity a growing concern for the audiology industry.+Save
MedWatch·Industry news·Business & finance·2w agoDemant CEO stays cautious as hearing aid makers race to launch new devicesCompetitive device launches and cautious revenue guidance from Demant signal continued market dynamism that could influence product availability, pricing, and technology options for clinics and dispensers.+Save
MedWatch·Financial report·Business & finance·3w agoCiti raises Demant price target, still expects it to outperform the marketDiverging analyst ratings between Demant and Sonova reflect shifting expectations in the competitive hearing aid market, which may signal broader industry trends relevant to clinic procurement and brand partnerships.+Save
MedWatch·Industry news·Business & finance·4w agoDemant extends market share gains in US veterans hearing aid channelSustained month-over-month share gains in the high-volume US veterans channel signal a meaningful competitive shift among the major hearing aid manufacturers.+Save
MedWatch·Industry news·Business & finance·4w agoDemant CEO: Bigger management team comes at the right time and adds capacityLeadership restructuring at one of the world's largest hearing aid groups may shape future product strategy, distribution relationships, and wholesale pricing — areas that ultimately affect clinic supply chains and partnerships.+Save
MedWatch·Industry news·Business & finance·4w agoDemant faces higher borrowing costs after record German acquisitionHigher borrowing costs for a major hearing aid manufacturer could affect its investment capacity, pricing strategy, and long-term competitiveness in the global market.+Save
MedWatch·Industry news·Business & finance·4w agoDemant’s new wholesale chief targets global leadership in hearing aidsLeadership signals from one of the world's largest hearing aid groups about global dominance aspirations could foreshadow strategic acquisitions, pricing shifts, or distribution changes relevant to wholesale partners and clinic owners.+Save
Hearing Tracker·Financial report·Business & finance·5w agoDemant Raises 2026 Outlook as Its Hearing Aid Sales Surge 17% in Q3A 17% organic growth surge at Demant signals continued strong consumer demand for hearing aids and reinforces the competitive pressure on the broader hearing healthcare market.+Save
MedWatch·Industry news·AI & technology·5w agoDemant CEO says AI hearing aids must strike the right balance on noiseThe tension between aggressive AI noise reduction and preserving meaningful auditory scene information is a central unresolved challenge in hearing aid signal processing, and a major manufacturer's public stance shapes the direction of future product development.+Save
MedWatch·Industry news·Hearing aids·5w agoDemant CEO says wave of hearing aid launches won’t upset customer behaviorSignals that major manufacturers expect premium-tier pricing to hold even amid simultaneous product launches, which could shape procurement costs and dispensing margins for clinic owners.+Save
MedWatch·Industry news·Hearing aids·5w agoDemant’s new flagship hearing aid is off to a flying start, but CEO won’t declare victory yetDemant's flagship launch intensifies competition in the premium hearing aid segment during the industry's peak fall release window, which may affect product availability, pricing, and dispensing choices for clinics.+Save
MedWatch·Financial report·Business & finance·6w agoNordea raises Demant price target on strong US demand for Oticon ZealSustained US demand for the Oticon Zeal suggests the premium hearing aid segment remains robust, which may influence clinic purchasing decisions and manufacturer investment in product development.+Save
MedWatch·Industry news·Business & finance·2mo agoHearing aid manufacturer falls behind in the growth race: A sign of fierce competitionShifts in competitive balance among the top hearing aid makers can influence product availability, pricing, and technology investment, which ultimately shapes the devices audiologists can offer patients.+Save
MedWatch·Industry news·Hearing aids·2mo agoAfter three-year wait, new platform aims to put WSA back on topWS Audiology's platform refresh after a three-year gap is a significant competitive development that could shift market-share dynamics among the top-five hearing aid manufacturers.+Save
MedWatch·Financial report·Business & finance·3mo agoMore US retail rivals pressure GN: "Larger than anticipated decline"Intensifying US retail competition is reshuffling market share among the largest hearing aid manufacturers, which could affect product availability, pricing, and supplier relationships for clinic owners.+Save
MedWatch·Industry news·Business & finance·3mo agoDemant closes KIND factory in Germany: “The technology was outdated”The closure signals ongoing consolidation and manufacturing modernisation within the global hearing aid industry, with Demant streamlining its KIND integration at the cost of around 200 jobs in Germany.+Save
Audiology Worldnews·Industry news·Hearing aids·3mo agoReveal is twice the launch anyone expected from Oticon: a dual AI system hearing aidOticon Reveal's dual-AI architecture signals an industry-wide push toward multi-model AI processing in premium hearing aids, potentially raising patient expectations and competitive pricing pressure across the market.+Save
MedWatch·Industry news·Business & finance·3mo agoDemant expects hefty refund: “Now, the net effect of customs duties is the other way around”A near-full tariff refund for Demant signals that trade policy reversals can meaningfully shift the financial outlook of major audiology manufacturers, which may influence product pricing and investment decisions across the sector.+Save
Audiology Worldnews·Financial report·Business & finance·3mo agoDemant reports 7% organic growth and upgrades 2026 outlookStrong organic growth at a market leader signals continued R&D investment and competitive pricing pressure across the hearing aid industry.+Save
MedWatch·Industry news·Business & finance·3mo agoDemant buys Amplifon’s UK chain: “We decided to make this a major project”This acquisition signals accelerating vertical integration in the UK hearing care market, which could reshape referral pathways, brand competition, and independent clinic economics.+Save
MedWatch·Industry news·Business & finance·3mo agoDemant CEO steps up efforts despite tough competition ahead: “We’re not done yet”Intensifying competition among major hearing-aid manufacturers could accelerate product innovation and affect pricing and supply options available to clinics.+Save
MedWatch·Industry news·Business & finance·3mo agoAnalyst expects tense competition following Demant's improved outlookIntensifying product competition among the Big Three hearing aid manufacturers could accelerate innovation and affect pricing and product availability for clinics and dispensers.+Save
MedWatch·Financial report·Business & finance·3mo agoDemant CEO on upward revision: “There is strong momentum in the business”Demant's upward financial revision signals continued market expansion in the hearing industry, which may influence competitive dynamics, pricing, and product investment across the sector.+Save
MedWatch·Financial report·Business & finance·3mo agoDemant upgrades outlook and launches new product initiativeDemant's upgraded growth forecast signals continued market expansion in hearing healthcare, which could influence competitive pricing, product availability, and clinic partnership strategies.+Save